Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Hematologic Diseases 1Colonic Neoplasms 1Brugada Syndrome 1Bone Marrow Diseases 1

Interventions

Oxaliplatin 6tislelizumab 3Irinotecan 3Fluorouracil 3Chemotherapy, Adjuvant 3Capecitabine 3sintilimab 2raltitrexed 2pembrolizumab 2Surgical Procedures, Operative 2Specimen Handling 2Neoadjuvant Therapy 2HMPL-013 2spartalizumab 1rimegepant sulfate 1encorafenib 1cemiplimab 1balstilimab 1XELOX 1Surgical Fixation Devices 1Radiofrequency Ablation 1Propranolol 1Preoperative Exercise 1Pemetrexed 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Mortality 1Magnetic Resonance Spectroscopy 1Leucovorin 1Laparoscopy 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Colonic Neoplasms × Electrocardiography × Clear all
NCT07364656 2026-01-23

Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors

IRCCS Policlinico S. Donato

Phase NA Not yet recruiting
196 enrolled
Gastrointestinal

Colonic Neoplasms, Brugada Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡